Abdullatif Akbari

513 citations
10 papers · 273 indexed · h-index 9
Topics
Adenosine and Purinergic Signaling (2 papers)Cancer Cells and Metastasis (2 papers)Cancer, Hypoxia, and Metabolism (2 papers)
Partner nations
IranIndiaGermany

In The Last Decade

Abdullatif Akbari

10 papers receiving 270 citations

Peers

Abdullatif Akbari
Comparison fields: 5 of 69
  • Molecular Biology 107
  • Infectious Diseases 77
  • Oncology 60
  • Cancer Research 54
  • Immunology 39
Replace Jiabin Xu with:
Jiabin Xu China
Peter Radvák Slovakia
Jeremy J.P. Shaw United States
Lulu Chen China
Chengkui Yang China
Hanna S. Hong United States
Mohammad Barghouth Sweden
Tiantian Li China
Isabel Huber‐Ruano Spain
Penghui Jia China
Abdullatif Akbari relative to Jiabin Xu China Jiabin Xu's profile →
Citations per field
00.5×1.5×2.1×
Jiabin Xu · 1×
Citations per year

Countries citing papers authored by Abdullatif Akbari

Since Specialization
Citations

This map shows the geographic impact of Abdullatif Akbari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdullatif Akbari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdullatif Akbari more than expected).

Fields of papers citing papers by Abdullatif Akbari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdullatif Akbari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdullatif Akbari. The network helps show where Abdullatif Akbari may publish in the future.

Co-authorship network of co-authors of Abdullatif Akbari

This figure shows the co-authorship network connecting the top 25 collaborators of Abdullatif Akbari. A scholar is included among the top collaborators of Abdullatif Akbari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdullatif Akbari. Abdullatif Akbari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 22
2 2
3 12
4 10
5 42
6 32
7 21
8 69
9 20
10 43

About Abdullatif Akbari

Abdullatif Akbari is a scholar working on Physiology, Cancer Research and Infectious Diseases, having authored 10 papers that have together received 273 indexed citations. Recurring topics across this work include Adenosine and Purinergic Signaling (2 papers), Cancer Cells and Metastasis (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Infectious Diseases (77 citations), Cancer Research (54 citations) and Physiology (13 citations). Abdullatif Akbari has collaborated with scholars based in Iran, India and Germany. Frequent co-authors include Hamidreza Zalpoor, Mohsen Nabi‐Afjadi, Maryam Bakhtiyari, Farhad Seif, Hossein Aazami, Majid Khoshmirsafa, Monireh Kamali, Majid Pornour, Masoud Dadashi and Maryam Azarian. Their work appears in journals such as Biomedicine & Pharmacotherapy, Cell Communication and Signaling and Inflammopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026